American Renal Associates Holdings (ARA) has agreed to pay $2 million to settle Securities and Exchange Commission (SEC) charges of accounting fraud allegedly perpetrated by three former financial executives at the dialysis provider.
American Renal Associates to pay $2M in accounting fraud case
